Sarepta Therapeutics, Inc. has grown revenue 31% a year over three years and 31% a year over five. Revenue growth, 3-year annual rate: +31% (Biotechnology median +21%). Revenue growth, 5-year rate: +31%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

SRPTSarepta Therapeutics, Inc.

HealthcareUSD

$19.47

$15.0052 weeks$24.45

Is it growing?

Is SRPT growing?

Sarepta Therapeutics, Inc. has grown revenue 31% a year over three years and 31% a year over five.

+31%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +31%
Revenue growth, 5-year rate · +31% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›